Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia

4 Apr 2019

Abstract excerpt

The glutamine amino acid transporter solute carrier family 38 member 1 (SLC38A1) is associated with the occurrence and progression of solid tumors. However, it has not yet been assessed in patients with hematologic malignancy. Herein, we investigated SLC38A1 expression and explored its clinical implications in acute myeloid leukemia (AML). The results showed that patients with high SLC38A1 expression had a lower...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31344987
DOI: 10.1002/jcp.28632

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemiaPMID 31344987Read ↗

The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid LeukemiaSemantic proximity Read ↗

PCAT18, as a novel differentially regulated long noncoding RNA in adult acute myeloid leukemia patients revealed by next‐generation sequencingSemantic proximity Read ↗

Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapySemantic proximity Read ↗

High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemiaSemantic proximity Read ↗

The surprising relationship between CD38 and lipid metabolic in acute myeloid leukemiaSemantic proximity Read ↗

Frequency and Prognostic Value of NPM1 Mutations in Sudanese Acute Myeloid Leukemia PatientsSemantic proximity Read ↗

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic TargetsSemantic proximity Read ↗

SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.Semantic proximity Read ↗

SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemiaSemantic proximity Read ↗

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid LeukaemiaSemantic proximity Read ↗

Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid LeukemiaSemantic proximity Read ↗

Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.